联系方式：400-650-8506
CNEN
产品名称 Hydroxy-DPAT hydrobromide, (R)-(+)-7- - DPAT, (R)-7-OH-
产品货号 Axon 1013 CAS [1021878-34-1] MF C16H25NO.HBrMW 328.29 Purity: 98% Optical purity: 98% ee Soluble in DMSO Description A Putative D3 dopamine receptor agonist (D3>D2>>D4 and D1); more active enantiomer of 7-OH-DPAT (Axon 1012), in comparison with (S)-(-)-7-OH-DPAT (Axon 1014) References Certificates Categories Extra info G Damsma et al. Pharmacological aspects of R-(+)-7-OH-DPAT, a putative dopamine D3 ligand. Eur. J. Pharmacol. 1993, 249, R9-R10.   LM Pritchard et al. 7-OH-DPAT and PD 128907 Selectively Activate the D3 Dopamine Receptor in a Novel Environment. Neuropsychopharmacology 2003, 28, 100–107.   Seeman and Van Tol. Dopamine receptor pharmacology. TiPS 1994, 15, 264.   Certificate of Analysis Material Safety Data Sheet CNS D3 A17 D3 agonist Chemical name (R)-7-Dipropylamino-5,6,7,8-tetrahydro-naphthalen-2-ol hydrobromide Parent CAS No. [82730-72-1] Inquire
产品价格 现货询价，电话：010-67529703
产品规格
产品品牌 axonmedchem
产品概述
产品详情

Hydroxy-DPAT hydrobromide, (R)-(+)-7- - DPAT, (R)-7-OH-

Based on 15 reference(s) in Google Scholar 8 10 15

Axon 1013

CAS [1021878-34-1]

MF C16H25NO.HBr
MW 328.29

  • Purity: 98%
  • Optical purity: 98% ee
  • Soluble in DMSO

Hydroxy-DPAT hydrobromide, (R)-(+)-7-

Description

A Putative D3 dopamine receptor agonist (D3>D2>>D4 and D1); more active enantiomer of 7-OH-DPAT (Axon 1012), in comparison with (S)-(-)-7-OH-DPAT (Axon 1014)
产品资料